Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Simulations Plus Inc - SIC # 7372 - PREPACKAGED SOFTWARE
Ticker
Exchange
SIC #
Website
Latest Ticker
SLP
Nasdaq
7372
https://www.simulations-plus.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Simulations Plus Inc
New AI Bot Predicts These 7 Stocks Will Mint Millionaires
- Apr 12th, 2024 5:53 pm
Simulations Plus (SLP) DILIsym Software Licenses Renewed by FDA
- Apr 8th, 2024 1:06 pm
Earnings Update: Simulations Plus, Inc. Beat Earnings And Now Analysts Have New Forecasts For This Year
- Apr 6th, 2024 12:37 pm
Simulations Plus Second Quarter 2024 Earnings: Beats Expectations
- Apr 5th, 2024 10:32 am
Simulations Plus, Inc. (NASDAQ:SLP) Q2 2024 Earnings Call Transcript
- Apr 4th, 2024 1:27 pm
U.S. FDA Renews DILIsym® Software Licenses for 7th Year
- Apr 4th, 2024 12:30 pm
Simulations Plus (SLP) Q2 Earnings & Revenues Beat Estimates
- Apr 4th, 2024 10:34 am
Q2 2024 Simulations Plus Inc Earnings Call
- Apr 4th, 2024 10:24 am
Simulations Plus Inc (SLP) Aligns with EPS Projections and Maintains Full-Year Guidance
- Apr 3rd, 2024 9:32 pm
Simulations Plus (SLP) Q2 Earnings and Revenues Surpass Estimates
- Apr 3rd, 2024 9:20 pm
Simulations Plus Reports Second Quarter Fiscal 2024 Financial Results
- Apr 3rd, 2024 8:34 pm
Simulations Plus (SLP) to Report Q2 Earnings: What's in Store?
- Apr 2nd, 2024 11:24 am
Simulations Plus Announces Second Quarter Fiscal Year 2024 Earnings and Conference Call Date
- Mar 20th, 2024 8:06 pm
Investing in Simulations Plus (NASDAQ:SLP) five years ago would have delivered you a 110% gain
- Mar 14th, 2024 1:50 pm
Simulations Plus to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum
- Mar 13th, 2024 12:30 pm
Director and 10% Owner Walter Woltosz Sells 20,000 Shares of Simulations Plus Inc (SLP)
- Mar 5th, 2024 10:01 pm
Simulations Plus and the University of Bath Awarded New FDA Grant
- Mar 5th, 2024 1:30 pm
Simulations Plus Extends Collaboration with Major Toxicology Research Agency
- Feb 15th, 2024 1:30 pm
Simulations Plus Launches Corporate Development Initiative
- Feb 13th, 2024 2:15 pm
Calculating The Intrinsic Value Of Simulations Plus, Inc. (NASDAQ:SLP)
- Feb 8th, 2024 10:54 am
Scroll